ENG rs16930129: Understanding This Genetic Variant
The rs16930129 variant is located within the ENG gene, which provides instructions for making the endoglin protein. This variant has been studied in the context of hereditary hemorrhagic telangiectasia (HHT), a condition characterized by abnormal blood vessel development.
What each genotype means
Typical ENG genotype
This genotype represents the most common sequence found in the general population for this location in the ENG gene. It is not associated with the pathogenic changes linked to hereditary hemorrhagic telangiectasia type 1. No specific clinical action is indicated based on this result.
This is the most common genotype observed across all major global populations.
Potential carrier status
This genotype indicates the presence of one copy of the variant. Because hereditary hemorrhagic telangiectasia is an autosomal dominant condition, you should discuss these results with a genetic counselor or clinician to determine if this specific variant is pathogenic and relevant to your health. Do not use this information to make medical decisions without professional clinical guidance.
This genotype is rare, consistent with the low frequency of pathogenic ENG variants in the general population.
Clinical evaluation recommended
This genotype indicates the presence of two copies of the variant. You should consult with a medical geneticist or a specialist in vascular disorders to interpret the clinical significance of this finding, as it may be associated with hereditary hemorrhagic telangiectasia. Please discuss any symptoms or family history with your healthcare provider to determine if further diagnostic testing is necessary.
This genotype is extremely rare in the general population.
What is rs16930129 and Where is it Located?
The genetic variant rs16930129 is a single nucleotide polymorphism (SNP) situated on chromosome 9. It is located within the ENG gene, which encodes the endoglin protein. In genetic databases, this specific marker has been noted for its presence in research studies investigating vascular health. It is important to note that rs16930129 has been merged into another identifier, rs11545664, in some databases, reflecting ongoing efforts to refine the human genetic map. Because it is a SNP, it represents a single position in the DNA sequence where individuals may differ by one nucleotide. Researchers track these variations to understand how they might influence biological processes or contribute to the risk of specific health conditions over time.
The Role of the ENG Gene
The ENG gene is essential for the production of endoglin, a protein that plays a critical role in the TGF-beta signaling pathway. This pathway is vital for maintaining the structural integrity of blood vessels throughout the body. When the ENG gene functions correctly, it helps regulate the growth and stability of the cells that line the interior of blood vessels. Disruptions or pathogenic variants in this gene can lead to a condition known as hereditary hemorrhagic telangiectasia (HHT), specifically type 1. HHT is an autosomal dominant disorder, meaning that a single altered copy of the gene is often sufficient to cause the condition. The resulting vascular issues can lead to telangiectasias, which are small, widened blood vessels near the surface of the skin or mucous membranes, as well as more serious internal arteriovenous malformations.
Research Associations and Evidence
The association between the ENG gene and HHT is well-established in medical literature. While many variants in ENG are known to be pathogenic and directly cause HHT, the specific role of rs16930129 is often discussed in the context of broader genetic studies rather than as a primary diagnostic marker for the disease. Evidence regarding this specific SNP is considered moderate in terms of its clinical impact compared to known disease-causing mutations. Research often includes this variant in panels or association studies to better understand the genetic architecture of vascular health. It is crucial to distinguish between common variants that may have subtle effects and rare, highly penetrant mutations that are definitively linked to clinical diagnoses of HHT. Always consult with a medical professional or a genetic counselor to interpret how specific genetic findings relate to personal health.
Population Frequency
The rs16930129 variant is generally considered rare in the general population. Genetic databases indicate that the frequency of the minor allele varies across different ancestral groups, though comprehensive data for all populations remains limited. Because HHT itself is a rare condition, variants associated with it are typically found at low frequencies in the general population. Researchers continue to use large-scale genomic datasets, such as gnomAD, to better estimate the prevalence of these variants across diverse ancestries. Understanding these frequencies helps scientists determine whether a variant is common enough to be considered a benign polymorphism or if it is rare enough to warrant further investigation for potential clinical significance.
What You Can Do With This Information
Genetic information can be complex, and it is important to approach it with the right perspective. If you have received results regarding the rs16930129 variant, remember that this information is for educational purposes and does not constitute a medical diagnosis. Genetic variants are only one piece of a much larger puzzle that includes your environment, lifestyle, and overall medical history. You cannot use this information to self-diagnose or make decisions about medical treatments. If you are concerned about hereditary conditions or your family health history, the most effective step is to speak with a healthcare provider or a certified genetic counselor. They can help you understand the clinical relevance of your results, discuss whether further testing is appropriate, and provide guidance based on your specific health context.
How common is this variant?
The rs16930129 variant is rare, with a minor allele frequency reported at approximately 0.1255 in some datasets, though this varies by ancestry.
Frequently asked questions
Is rs16930129 a cause of HHT?
While the ENG gene is strongly associated with HHT, rs16930129 is a specific SNP within that gene. It is not typically classified as a primary pathogenic mutation that causes HHT on its own.
Should I be worried if I have this variant?
Having a specific genetic variant does not necessarily mean you have or will develop a disease. You should discuss any genetic findings with a healthcare professional who can interpret them in the context of your overall health.
Where can I get tested for HHT?
Clinical genetic testing for HHT is typically ordered by a physician, such as a geneticist or a specialist in vascular disorders. They will determine if testing is appropriate based on your symptoms and family history.
Does this variant affect medication response?
There is no current evidence suggesting that rs16930129 influences how you respond to specific medications. Always consult your clinician or pharmacist before making changes to your medication regimen.
Sources & further reading
Educational information only, last refreshed 10/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs16930129?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in ENG
Genetic variant identified in the ENG gene, relevant for clinical screening of vascular disorders.
A known pathogenic mutation in the ENG gene linked to vascular malformations.
Pathogenic variant in the ENG gene associated with hereditary hemorrhagic telangiectasia type 1.
A variant in the ENG gene potentially impacting protein function related to vascular development.
This variant is located within the ENG gene, which is associated with hereditary hemorrhagic telangiectasia.
Clinically significant variant in the ENG gene associated with hereditary hemorrhagic telangiectasia.